Biopharma R&D Information &
Custom Report Preparation

La Merie Publishing is an independent business information provider for the biotechnology and pharmaceutical industry. We publish proprietary reports and prepare custom reports.

Press Room

Posted May 13, 2016

Strong emergence of T-cell redirecting bispecific antibodies in clinical proof-of-concept studies

STUTTGART, Germany I May 13, 2016 I Immunotherapy of cancer with direct or indirect use of T-cells is one of the most exciting fields in cancer research. Direct T-cell therapy implies the ex vivo engineering of autologous or allogeneic T-cells